Since PDPK1 up‐regulation and activation have been recently shown to confer chemoresistance in breast,45 glioblastoma,46 neuroblastoma47 and pancreatic cancer cells,48 we asked whether inhibition of PDPK1 might enhance chemotherapy sensitivity in PCa cells. Here, PDPK1 is linked to glioblastoma.